Summit Trail Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$793K Buy
6,557
+197
+3% +$23.8K 0.01% 557
2025
Q1
$734K Buy
6,360
+580
+10% +$67K 0.02% 194
2024
Q4
$562K Buy
5,780
+603
+12% +$58.7K 0.02% 197
2024
Q3
$595K Sell
5,177
-376
-7% -$43.2K 0.01% 361
2024
Q2
$591K Buy
5,553
+956
+21% +$102K 0.02% 337
2024
Q1
$462K Buy
4,597
+274
+6% +$27.5K 0.01% 351
2023
Q4
$436K Buy
4,323
+685
+19% +$69.2K 0.01% 308
2023
Q3
$371K Sell
3,638
-623
-15% -$63.5K 0.01% 332
2023
Q2
$430K Buy
4,261
+716
+20% +$72.3K 0.02% 295
2023
Q1
$326K Buy
+3,545
New +$326K 0.01% 305
2022
Q1
Sell
-3,445
Closed -$301K 363
2021
Q4
$301K Buy
+3,445
New +$301K 0.02% 232
2018
Q4
Sell
-4,741
Closed -$366K 192
2018
Q3
$366K Buy
4,741
+768
+19% +$59.3K 0.08% 130
2018
Q2
$269K Sell
3,973
-21,717
-85% -$1.47M 0.09% 114
2018
Q1
$1.48M Buy
25,690
+4,992
+24% +$288K 0.25% 87
2017
Q4
$1.68M Buy
+20,698
New +$1.68M 0.21% 90